StockWatch
·

Indo Farm Equipment Ltd

BSE: 544328

P/L Snapshot

Q1 FY27 · standalone

vs Q4 FY26·vs Q1 FY26
Revenue
105.84
-18.3%+14.3%
Expenditure
98.78
-16.2%+14.6%
Net Profit
5.06
-38.5%+10.3%
OPM %
11.61%
-1.23pp+0.11pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
0.0036.2772.54108.81145.09Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Price Chart
Reports

Tractor surge masks crane halt, margins compressed

capacity expansion · dealer bottleneck · margin recovery

TranscriptDeep diveQ1 FY2717 Aug 20266 minAutomobile

Indo Farm Q1FY27: consolidated PAT +4% YoY, margins compress despite 14.5% revenue growth

farm equipment · tractors · cranes

ResultsQ1 FY2708 Aug 20263 minAutomobile
Latest
Board Meeting8 Aug, 6:21 pm

Indo Farm Q1FY27: consolidated PAT +4% YoY, margins compress despite 14.5% revenue growth

Indo Farm Equipment's consolidated Q1 FY27 (quarter ended June 30, 2026) revenue rose 14.5% YoY to ₹110.24 Cr, but consolidated PAT grew just 4.1% YoY to ₹5.66 Cr (basic EPS ₹1.18 vs ₹1.13) — profit growth lagging revenue growth on both fronts. Sequentially, revenue fell 17.7% and PAT fell 35.1% versus Q4 FY26 (₹133.99 Cr / ₹8.72 Cr), which is largely seasonal: farm-equipment demand is stronger in the January-March window ahead of the sowing season, so the QoQ drop should not be read as a slowdown signal on its own — the YoY read is the one that matters, and it shows margin erosion, not just softer sequential demand. The compression shows up on both lines: consolidated NPM (PAT/total income) fell to 5.08% from 5.54% a year ago and 6.45% last quarter; operating margin (EBIT ex-other-income/revenue) slipped to 13.12% from 13.68% YoY and 13.90% QoQ. Cost of materials (+15.9%), employee costs (+17.5%) and other expenses (+23.6%) all grew faster than the 14.5% topline, squeezing the operating line even as finance costs actually fell YoY (₹4.05 Cr vs ₹4.41 Cr). Segment-wise the growth mix is lopsided: tractor revenue jumped 36.3% YoY to ₹52.08 Cr, well ahead of management's 25-30% FY27 guidance pace, while crane revenue was flat at ₹52.86 Cr (-0.4% YoY) against a 15-20% guided growth rate — consistent with the new pick-and-carry and tower crane capacities not yet being commercial. The NBFC subsidiary Barota Finance, now broken out as its own segment, added ₹5.31 Cr of revenue and ₹2.27 Cr of segment profit, lifting consolidated PBT ₹0.78 Cr above the standalone figure. Against management's own May 2026 guidance of 20-25% FY27 revenue growth and a ~12.5% FY27 EBITDA margin, the quarter tracks below the revenue growth rate (14.5% YoY) though the operating margin (13.12%) still sits above the full-year target — for now. No Q1-specific street estimates could be found; a prior FY27 outlook piece (Univest) cited a full-year analyst PAT growth expectation of roughly 15-20%, which this quarter's 4.1% YoY PAT growth trails, though a single quarter is not directly comparable to a full-year estimate. No management press release accompanied this filing beyond the standard board-outcome letter, so there is no fresh commentary to reconcile against the numbers. The quarter's other disclosed developments — the August 8 board meeting itself, the routine appointment of an internal auditor, and the AGM notice for FY26 — are procedural and don't bear on the print. What this sets up: management's own Q2 FY27 markers (pick-and-carry crane commercial production at 30-35% initial utilization, tower crane production at 50-60% utilization) are the next checkpoints — if cranes stay flat past Q2 despite the new lines going live, the FY27 20-25% revenue guidance comes under real pressure given tractors alone would need to keep compounding at a 36%+ clip to compensate. Of the ₹70.07 Cr earmarked from IPO proceeds for the crane capacity expansion, ₹44.67 Cr remains unutilized as of June 30, 2026.

8 Aug 2026, 06:21 pm

Corporate Events

Board MeetingINDOFARM
2026
23Sep

Board Meeting

To receive, consider and adopt the Audited Standalone and Co…

BSE Filing ↗
Board MeetingINDOFARM
2026
8Aug

Board Meeting

The meeting of the Board of Directors is scheduled to consid…

BSE Filing ↗
Board MeetingINDOFARM
2025
12Nov

Board Meeting

Consider and approve Intimation of Board Meeting, consider a…

BSE Filing ↗
Board MeetingINDOFARM
2025
28May

Board Meeting

Consider and approve Intimation of Board Meeting, Disclosure…

BSE Filing ↗
Board MeetingINDOFARM
2025
13Feb

Board Meeting

Board Meeting Intimation, Consider, approve and take on reco…

BSE Filing ↗